Literature DB >> 6821706

Conservation of myeloid surface antigens on primate granulocytes.

N L Letvin, R F Todd, L S Palley, S F Schlossman, J D Griffin.   

Abstract

Monoclonal antibodies reactive with myeloid cell surface antigens were used to study evolutionary changes in granulocyte surface antigens from primate species. Certain of these granulocyte membrane antigens are conserved in phylogenetically distant species, indicating the potential functional importance of these structures. The degree of conservation of these antigens reflects the phylogenetic relationship between primate species. Furthermore, species of the same genus show similar patterns of binding to this panel of anti-human myeloid antibodies. This finding of conserved granulocyte surface antigens suggests that non-human primates may provide a model system for exploring uses of monoclonal antibodies in the treatment of human myeloid disorders.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6821706

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. In vivo stability of disulfide-linked immunotoxin conjugates.

Authors:  N L Letvin; V S Goldmacher; J Ritz; J M Yetz; S F Schlossman; J M Lambert
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

2.  Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion.

Authors:  P J Simpson; R F Todd; J C Fantone; J K Mickelson; J D Griffin; B R Lucchesi
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

3.  CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide.

Authors:  S D Wright; S M Levin; M T Jong; Z Chad; L G Kabbash
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

4.  In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. Delivery of ribosome-inactivating proteins to spleen and lymph node T cells.

Authors:  N L Letvin; L V Chalifoux; K A Reimann; J Ritz; S F Schlossman; J M Lambert
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

5.  In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. IV. Cytotoxic effect of an anti-T11-gelonin immunotoxin.

Authors:  K A Reimann; V S Goldmacher; J M Lambert; L V Chalifoux; S B Cook; S F Schlossman; N L Letvin
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

6.  Acquired immunodeficiency syndrome in a colony of macaque monkeys.

Authors:  N L Letvin; K A Eaton; W R Aldrich; P K Sehgal; B J Blake; S F Schlossman; N W King; R D Hunt
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

7.  Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen.

Authors:  S D Wright; J I Weitz; A J Huang; S M Levin; S C Silverstein; J D Loike
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

8.  A naturally occurring bone marrow-chimeric primate. II. Environment dictates restriction on cytolytic T lymphocyte-target cell interactions.

Authors:  J Picus; K Holley; W R Aldrich; J D Griffin; N L Letvin
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

9.  Leishmania promastigotes require opsonic complement to bind to the human leukocyte integrin Mac-1 (CD11b/CD18).

Authors:  D M Mosser; T A Springer; M S Diamond
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.